| Phage therapy for respiratory infections RYK Chang, M Wallin, Y Lin, SSY Leung, H Wang, S Morales, HK Chan Advanced drug delivery reviews 133, 76-86, 2018 | 155 | 2018 |
| Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection RY Chang, J Wong, A Mathai, S Morales, E Kutter, W Britton, J Li, ... European Journal of Pharmaceutics and Biopharmaceutics 121, 1-13, 2017 | 106 | 2017 |
| Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound … RYK Chang, T Das, J Manos, E Kutter, S Morales, HK Chan The AAPS journal 21, 1-8, 2019 | 93 | 2019 |
| Dry powder inhalable formulations for anti-tubercular therapy T Parumasivam, RYK Chang, S Abdelghany, TT Ye, WJ Britton, HK Chan Advanced drug delivery reviews 102, 83-101, 2016 | 87 | 2016 |
| Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa Y Lin, RYK Chang, WJ Britton, S Morales, E Kutter, HK Chan International journal of pharmaceutics 551 (1-2), 158-165, 2018 | 85 | 2018 |
| Proof-of-principle study in a murine lung infection model of antipseudomonal activity of phage PEV20 in a dry-powder formulation RYK Chang, K Chen, J Wang, M Wallin, W Britton, S Morales, E Kutter, ... Antimicrobial Agents and Chemotherapy 62 (2), 10.1128/aac. 01714-17, 2018 | 84 | 2018 |
| Anti-tuberculosis bacteriophage D29 delivery with a vibrating mesh nebulizer, jet nebulizer, and soft mist inhaler NB Carrigy, RY Chang, SSY Leung, M Harrison, Z Petrova, WH Pope, ... Pharmaceutical research 34, 2084-2096, 2017 | 82 | 2017 |
| SWATH analysis of the synaptic proteome in Alzheimer's disease RYK Chang, N Etheridge, AS Nouwens, PR Dodd Neurochemistry international 87, 1-12, 2015 | 64 | 2015 |
| Novel antimicrobial agents for combating antibiotic-resistant bacteria RYK Chang, SC Nang, HK Chan, J Li Advanced drug delivery reviews 187, 114378, 2022 | 63 | 2022 |
| Topical application of bacteriophages for treatment of wound infections RYK Chang, S Morales, Y Okamoto, HK Chan Translational Research 220, 153-166, 2020 | 62 | 2020 |
| Dry powder pharmaceutical biologics for inhalation therapy RYK Chang, MYT Chow, D Khanal, D Chen, HK Chan Advanced Drug Delivery Reviews 172, 64-79, 2021 | 57 | 2021 |
| Storage stability of inhalable phage powders containing lactose at ambient conditions RYK Chang, M Wallin, E Kutter, S Morales, W Britton, J Li, HK Chan International journal of pharmaceutics 560, 11-18, 2019 | 57 | 2019 |
| Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections Y Lin, RYK Chang, WJ Britton, S Morales, E Kutter, J Li, HK Chan European Journal of Pharmaceutics and Biopharmaceutics 142, 543-552, 2019 | 53 | 2019 |
| The synaptic proteome in Alzheimer's disease RYK Chang, AS Nouwens, PR Dodd, N Etheridge Alzheimer's & Dementia 9 (5), 499-511, 2013 | 49 | 2013 |
| Bacteriophage-delivering hydrogels: Current progress in combating antibiotic resistant bacterial infection HY Kim, RYK Chang, S Morales, HK Chan Antibiotics 10 (2), 130, 2021 | 47 | 2021 |
| Inhalation delivery technology for genome-editing of respiratory diseases MYT Chow, RYK Chang, HK Chan Advanced Drug Delivery Reviews 168, 217-228, 2021 | 43 | 2021 |
| Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilization RYK Chang, PCL Kwok, D Khanal, S Morales, E Kutter, J Li, HK Chan Bioengineering & translational medicine 5 (2), e10159, 2020 | 43 | 2020 |
| Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model Y Lin, D Quan, RYK Chang, MYT Chow, Y Wang, M Li, S Morales, ... European Journal of Pharmaceutics and Biopharmaceutics 158, 166-171, 2021 | 37 | 2021 |
| Phage–antibiotic therapy as a promising strategy to combat multidrug-resistant infections and to enhance antimicrobial efficiency C Liu, Q Hong, RYK Chang, PCL Kwok, HK Chan Antibiotics 11 (5), 570, 2022 | 36 | 2022 |
| Pharmacokinetics and time-kill study of inhaled antipseudomonal bacteriophage therapy in mice MYT Chow, RYK Chang, M Li, Y Wang, Y Lin, S Morales, AJ McLachlan, ... Antimicrobial Agents and Chemotherapy 65 (1), 10.1128/aac. 01470-20, 2020 | 35 | 2020 |
